{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:08:32Z","timestamp":1787616512202,"version":"build-2736575974"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The metastasis of laryngeal squamous cell carcinoma (LSCC) is not only caused by the tumor itself but is also closely related to cancer-associated fibroblasts (CAFs). The epithelial-mesenchymal transition (EMT) serves as a key event during its metastasis. However, the specific mechanisms underlying LSCC metastasis remain uncertain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A wound healing assay was utilized to evaluate the migratory capacity of LSCC cells (TU686 and TU212 cells). Immunofluorescence staining and Western blot analysis were conducted to demonstrate the expression levels of associated proteins. Migration and invasion assays were employed to assess the migration and invasion abilities of LSCC cells in vitro. A nude mouse metastasis model was used to detect LSCC metastasis in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Our results revealed that interleukin-33 (IL-33) enhanced the migratory, invasive, and EMT capabilities of LSCC cells. In the co-culture model of LSCC cells and CAFs, silencing the expression of IL-33 inhibited the migratory, invasive, and metastasis potential of LSCC cells both in vitro and in vivo.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IL-33 derived from CAFs mediates EMT to promote the metastasis of LSCC cells. The findings of our study not only provide a new mechanism for the activation of CAFs and the metastasis of LSCC but also offer theoretical significance and application value for more effective prevention and treatment strategies in clinical practice.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s40001-025-03431-4","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:25:22Z","timestamp":1763702722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["CAF derived IL-33 mediated EMT to promote the metastasis of LSCC cells"],"prefix":"10.1186","volume":"30","author":[{"given":"Liyun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuixian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"3431_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"3431_CR2","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.3390\/biomedicines10092148","volume":"10","author":"KG Anastasios Goulioumis","year":"2022","unstructured":"Anastasios Goulioumis KG. Epithelial-to-mesenchymal transition in metastasis: focus on Laryngeal carcinoma. Biomedicines. 2022;10(9):2148.","journal-title":"Biomedicines"},{"issue":"20","key":"3431_CR3","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.3390\/cancers13205135","volume":"13","author":"AR Subbalakshmi","year":"2021","unstructured":"Subbalakshmi AR, Sahoo S, McMullen I, Saxena AN, Venugopal SK, Somarelli JA, et al. KLF4 induces mesenchymal\u2013Epithelial transition (MET) by suppressing multiple EMT-inducing transcription factors. Cancers. 2021;13(20):5135.","journal-title":"Cancers"},{"issue":"9","key":"3431_CR4","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1111\/cas.15359","volume":"113","author":"L Manevich","year":"2022","unstructured":"Manevich L, Okita Y, Okano Y, Sugasawa T, Kawanishi K, Poullikkas T, et al. Glycoprotein NMB promotes tumor formation and malignant progression of laryngeal squamous cell carcinoma. Cancer Sci. 2022;113(9):3244\u201354.","journal-title":"Cancer Sci"},{"issue":"1","key":"3431_CR5","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3390\/biom13010067","volume":"13","author":"JS Owen","year":"2023","unstructured":"Owen JS, Clayton A, Pearson HB. Cancer-associated fibroblast heterogeneity, activation and function: implications for prostate cancer. Biomolecules. 2023;13(1):67.","journal-title":"Biomolecules"},{"key":"3431_CR6","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1186\/s12885-020-07376-1","volume":"20","author":"N Ortiz-Otero","year":"2020","unstructured":"Ortiz-Otero N, Marshall JR, Lash B. Chemotherapy-induced release of circulating-tumor cells into the bloodstream in collective migration units with cancer-associated fibroblasts in metastatic cancer patients. BMC Cancer. 2020;20:873.","journal-title":"BMC Cancer"},{"key":"3431_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14134-w","volume":"11","author":"F Pelon","year":"2020","unstructured":"Pelon F, Bourachot B, Kieffer Y, Magagna I, Mermet-Meillon F, Bonnet I, et al. Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms. Nat Commun. 2020;11:404.","journal-title":"Nat Commun"},{"key":"3431_CR8","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s41577-021-00540-z","volume":"14","author":"S Davidson","year":"2021","unstructured":"Davidson S, Coles M, Thomas T, Kollias G, Ludewig B, Turley S, et al. Fibroblasts as immune regulators in infection, inflammation and cancer. Nat Rev Immunol. 2021;14:704\u201317.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3431_CR9","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3390\/cancers12092479","volume":"12","author":"X Wang","year":"2020","unstructured":"Wang X, Semba T, Phi LTH, Chainitikun S, Iwase T, Lim B, et al. Targeting Signaling Pathways in Inflammatory Breast Cancer. Cancers. 2020;12(9):2479.","journal-title":"Cancers"},{"issue":"1","key":"3431_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24108","volume":"36","author":"Wu Chunping","year":"2022","unstructured":"Chunping Wu, Wang M, Huang Q, Guo Y, Gong H, Chunyan Hu, et al. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients. J Clin Lab Anal. 2022;36(1):e24108.","journal-title":"J Clin Lab Anal"},{"issue":"167","key":"3431_CR11","doi-asserted-by":"publisher","first-page":"220144","DOI":"10.1183\/16000617.0144-2022","volume":"32","author":"AA Calderon","year":"2023","unstructured":"Calderon AA, Dimond C, Choy DF, Pappu R, Grimbaldeston MA, Mohan D, et al. Targeting\u00a0interleukin-33\u00a0and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD. Eur Respir Rev. 2023;32(167):220144.","journal-title":"Eur Respir Rev"},{"issue":"12","key":"3431_CR12","first-page":"24","volume":"3","author":"OO Oyesola","year":"2020","unstructured":"Oyesola OO, Duque C, Huang LC, Larson EM, Fr\u00fch SP, Webb LM, et al. The prostaglandin D2 receptor CRTH2 promotes IL-33-induced ILC2 accumulation in the lung. J Immunol. 2020;3(12):24\u20138.","journal-title":"J Immunol"},{"issue":"1","key":"3431_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-018-1223-3","volume":"36","author":"M Kieler","year":"2018","unstructured":"Kieler M, Unseld M, Wojta J, Kaider A, Bianconi D, Demyanets S, et al. Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy. Med Oncol. 2018;36(1):1.","journal-title":"Med Oncol"},{"key":"3431_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1021609","volume":"12","author":"MPS Damasio","year":"2022","unstructured":"Damasio MPS, Nascimento CS, Andrade LM, de Oliveira VL, Calzavara-Silva CE. The role of T-cells in head and neck squamous cell carcinoma: from immunity to immunotherapy. Front Oncol. 2022;12:1021609.","journal-title":"Front Oncol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03431-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03431-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T05:25:23Z","timestamp":1763702723000},"score":1,"resource":{"primary":{"URL":"https:\/\/eurjmedres.biomedcentral.com\/articles\/10.1186\/s40001-025-03431-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3431"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03431-4","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"9 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animals were approved by based on the protocol was approved by the Experimental Animal Ethics Committee at Shanghai Jiao Tong University School of Medicine in accordance with the Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1147"}}